Literature DB >> 18853874

Ventilation and drug delivery to the paranasal sinuses: studies in a nasal cast using pulsating airflow.

Winfried Möller1, Uwe Schuschnig, Gabriele Meyer, Heribert Mentzel, Manfred Keller.   

Abstract

BACKGROUND: Although there is a high incidence of nasal disorders including chronic sinusitis, there is limited success in the topical drug delivery to the nose and the paranasal sinuses. This is caused by the nose being an efficient filter for inhaled aerosol particles and the paranasal sinuses being virtually non ventilated
METHOD: The objective of this study was to visualize the efficiency of sinus ventilation in a nasal cast using dynamic 81mKr-gas imaging in combination with pulsating airflows. Furthermore, the efficiency of the deposition of radiolabelled aerosol was assessed.
RESULTS: Pulsation increased ventilation efficiency of the sinuses more than fivefold and aerosol deposition efficiency more than twentyfold, compared to delivery without pulsation. Furthermore pulsation increased aerosol deposition in the nasal airways by a factor of three. Using pulsating airflow Kr-gas ventilation and aerosol deposition efficiencies increased with increasing sinus volume. Pulsating airflow resulted in a deposition of up to 8% of the nebulized drug within the sinuses compared to 0.2% without pulsation.
CONCLUSIONS: The study demonstrates the high efficiency of a pulsating airflow in paranasal sinus ventilation and aerosolized drug delivery. This proves that topical drug delivery to the paranasal sinuses in relevant quantities is possible.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18853874

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  10 in total

1.  Ventilation imaging of the paranasal sinuses using xenon-enhanced dynamic single-energy CT and dual-energy CT: a feasibility study in a nasal cast.

Authors:  Sven F Thieme; Winfried Möller; Sven Becker; Uwe Schuschnig; Oliver Eickelberg; Andreas D Helck; Maximilian F Reiser; Thorsten R C Johnson
Journal:  Eur Radiol       Date:  2012-05-18       Impact factor: 5.315

Review 2.  Pathogenesis and management of nasal polyposis in cystic fibrosis.

Authors:  Jochen G Mainz; Assen Koitschev
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

3.  Topical Drug Delivery for Chronic Rhinosinusitis.

Authors:  Jonathan Liang; Andrew P Lane
Journal:  Curr Otorhinolaryngol Rep       Date:  2012-12-27

4.  Impact of airborne particle size, acoustic airflow and breathing pattern on delivery of nebulized antibiotic into the maxillary sinuses using a realistic human nasal replica.

Authors:  Lara Leclerc; Jérémie Pourchez; Gérald Aubert; Sandrine Leguellec; Laurent Vecellio; Michèle Cottier; Marc Durand
Journal:  Pharm Res       Date:  2014-03-04       Impact factor: 4.200

Review 5.  Inhalable Antimicrobials for Treatment of Bacterial Biofilm-Associated Sinusitis in Cystic Fibrosis Patients: Challenges and Drug Delivery Approaches.

Authors:  Sylvia Natalie Kłodzińska; Petra Alexandra Priemel; Thomas Rades; Hanne Mørck Nielsen
Journal:  Int J Mol Sci       Date:  2016-10-09       Impact factor: 5.923

6.  Xenon-Enhanced Dynamic Dual-Energy CT Is Able to Quantify Sinus Ventilation Using Laminar and Pulsating Air-/Gas Flow Before and After Surgery: A Pilot Study in a Cadaver Model.

Authors:  Sven Becker; Tilman Huppertz; Winfried Möller; Miriam Havel; Maria Schuster; Anne Merle Becker; Martin Sailer; Uwe Schuschnig; Thorsten R Johnson
Journal:  Front Allergy       Date:  2022-02-16

7.  Sphenoidotomy kinetics in patients with chronic rhinosinusitis without nasal polyps.

Authors:  Panagiotis D Pyriochos; Konstantinos Markou; Jannis Constantinidis; Iordanis Konstantinidis
Journal:  Acta Otorhinolaryngol Ital       Date:  2022-02-07       Impact factor: 2.618

Review 8.  In Vitro Anatomical Models for Nasal Drug Delivery.

Authors:  Gerallt Williams; Julie D Suman
Journal:  Pharmaceutics       Date:  2022-06-26       Impact factor: 6.525

Review 9.  Novel drug-delivery systems for patients with chronic rhinosinusitis.

Authors:  Silviu Albu
Journal:  Drug Des Devel Ther       Date:  2012-05-31       Impact factor: 4.162

10.  Validation of anatomical models to study aerosol deposition in human nasal cavities.

Authors:  Sandrine Le Guellec; Deborah Le Pennec; Stephane Gatier; Lara Leclerc; Maria Cabrera; Jeremie Pourchez; Patrice Diot; Gregory Reychler; Laurent Pitance; Marc Durand; François Jamar; Laurent Vecellio
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.